 This study examined the efficacy and safety of transcatheter arterial embolization, TAE, as a treatment for bleeding caused by COVID-19. The results showed that TAE was successful in treating all patients who underwent the procedure, regardless of whether they had coagulopathy or not. Additionally, no complications related to the procedure were reported. Therefore, this study suggests that TAE can be used safely and effectively to treat bleeding caused by COVID-19. This article was authored by Roberto Minasai, Federico Fontana, Massimo Venturini, and others.